Etcembly Ltd Employee Directory
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Etcembly Ltd is a biotechnology research company headquartered in Harwell, England, focused on advancing immune repertoire analysis through computational methods. Its platform, EMLy, integrates large language models with established immune repertoire techniques, complemented by an in silico engineering interface intended to accelerate discovery and optimization in immunotherapy development. The approach aims to shorten the time from concept to actionable insights, enabling researchers to identify biomarkers, predict therapeutic outcomes, and design treatment strategies with greater confidence. The organization operates within the biotech research space and pursues collaborations to push forward next-generation immunotherapies that can impact patient care. Etcembly has engaged in partnerships with other biotech entities, including recent collaborations announced in 2026, which illustrate its active participation in advancing antibody and TCR engineering efforts. The company serves customers in research and clinical development contexts that seek data-driven tools to analyze immune responses and to support the design and evaluation of immunotherapies. With a team based in the UK and a focus on leveraging AI-driven analysis for immune research, Etcembly positions itself at the intersection of computational science and immunology.
1-888-653-2347 
support@leadiq.com 
